We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21.5B
AUM Growth
–
Cap. Flow
+$20.7B
Cap. Flow
% of AUM
96.15%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
248
New
248
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.7B |
| 2 |
ExxonMobil
XOM
|
+$1.45B |
| 3 |
Coca-Cola
KO
|
+$1.29B |
| 4 |
Chevron
CVX
|
+$907M |
| 5 |
Altria Group
MO
|
+$744M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 28.9% |
| 2 | Energy | 25.56% |
| 3 | Financials | 12.39% |
| 4 | Healthcare | 9.74% |
| 5 | Technology | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cullen/Frost Bankers
CFR
$10.3B
| $254K | ﹤0.01% |
+3,417
| New | +$245K |
|
227
Teva Pharmaceuticals
TEVA
$41.2B
| $253K | ﹤0.01% |
+6,300
| New | +$248K |
|
228
Devon Energy
DVN
$50.9B
| $244K | ﹤0.01% |
+3,943
| New | +$242K |
|
229
A.O. Smith
AOS
$8.24B
| $243K | ﹤0.01% |
+9,000
| New | +$231K |
|
|
COL
230
DELISTED
Rockwell Collins
COL
| $242K | ﹤0.01% |
+3,279
| New | +$233K |
|
231
Chord Energy
CHRD
$7.78B
| $235K | ﹤0.01% |
+5,000
| New | +$248K |
|
|
STR
232
DELISTED
QUESTAR CORP
STR
| $233K | ﹤0.01% |
+10,140
| New | +$233K |
|
233
CVS Health
CVS
$134B
| $230K | ﹤0.01% |
+3,219
| New | +$207K |
|
234
Eaton
ETN
$150B
| $229K | ﹤0.01% |
+3,003
| New | +$214K |
|
|
HBI
235
DELISTED
Hanesbrands
HBI
| $221K | ﹤0.01% |
+12,588
| New | +$209K |
|
236
American International
AIG
$41.8B
| $220K | ﹤0.01% |
+4,312
| New | +$215K |
|
237
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $215K | ﹤0.01% |
+5,736
| New | +$207K |
|
|
TOO
238
DELISTED
Teekay Offshore Partners L.P.
TOO
| $215K | ﹤0.01% |
+6,500
| New | +$212K |
|
239
Alcoa
AA
$11.9B
| $213K | ﹤0.01% |
+8,323
| New | +$185K |
|
240
Howard Hughes
HHH
$3.87B
| $209K | ﹤0.01% |
+1,827
| New | +$198K |
|
241
Hartford Financial Services
HIG
$39.2B
| $208K | ﹤0.01% |
+5,744
| New | +$198K |
|
242
PNC Financial Services
PNC
$99.2B
| $205K | ﹤0.01% |
+2,637
| New | +$198K |
|
243
Eagle Materials
EXP
$6.35B
| $203K | ﹤0.01% |
+2,625
| New | +$198K |
|
|
KMI.WS
244
DELISTED
Kinder Morgan Inc
KMI.WS
| $102K | ﹤0.01% |
+25,010
| New | +$108K |
|
|
DYAX
245
DELISTED
DYAX CORPORATION
DYAX
| $75K | ﹤0.01% |
+10,000
| New | +$76K |
|
|
SVNT
246
DELISTED
SAVIENT PHARMACEUTICALS INC
SVNT
| $0 | ﹤0.01% |
+13,860
| New | +$7.02K |
|
Similar funds
HF
Fayez Sarofim & Co's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Fayez Sarofim & Co, which disclosed 248 positions worth $21.5B. Its ten largest holdings account for 44% of the portfolio.
Its largest position is Philip Morris: 19,441,921 shares worth $1.69B.
By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, followed by Energy and Financials.
- Fayez Sarofim & Co's largest Q4 2013 buy was Philip Morris: 19,441,921 shares worth $1.69B.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $21.5B portfolio in Q4 2013.
- Fayez Sarofim & Co disclosed 248 positions in Q4 2013, its first 13F filing on record.
Based on Fayez Sarofim & Co's 13F filing for Q4 2013, filed 14 Feb 2014.